[ORAL THERAPY OF DIABETES MELLITUS WITH 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN)].
D002271:Carbutamide; D003920:Diabetes Mellitus; D003875:Drug Eruptions; D004358:Drug Therapy; D004361:Drug Tolerance; D007004:Hypoglycemic Agents; D011743:Pyrimidines; D013449:Sulfonamides; D014044:Tolbutamide; D014116:Toxicology
D007004:Hypoglycemic Agents; D011743:Pyrimidines; D013449:Sulfonamides; D014044:Tolbutamide; D002271:Carbutamide; C030986:pyrimidine
ANTIDIABETICS; CARBUTAMIDE; DERMATITIS MEDICAMENTOSA; DRUG THERAPY; DRUG TOLERANCE; PYRIMIDINES; SULFONAMIDES; TOLBUTAMIDE; TOXICOLOGIC REPORT
ORALE BEHANDLUNG DES DIABETES MELLITUS MIT 2-BENZOLSULFONAMIDO-5(BETA-METHOXY-AETHOXY)-PYRIMIDIN (GLYCODIAZIN)